MTOR and central nervous system cancer: As it is known from the literature, in the vast majority of gliomas, changes in signal transmission from the cell membrane to the nucleus through intracellular signaling pathways, including PI3K-AKT/PKB-mTOR, are observed (Ludwig and Kornblum 2017).